产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
| 名称 | DB (弥漫大B细胞淋巴瘤细胞) (STR鉴定正确) |
| 种属 | 人 |
| 生长特性 | 悬浮细胞 |
| 细胞形态 | 淋巴母细胞样 |
| 冻存条件 | 冻存液：55% 基础培养基+40%FBS+5%DMSO 温度：液氮 |
| 培养方案A（默认） |
培养条件:
气相：空气，95%；CO2，5%, 温度：37℃
|
| 推荐传代比例 | 1:3-1:5 |
| 推荐换液频率 | 2-3次/周 |
| 注意事项 | 该细胞为悬浮细胞，请注意离心收集细胞悬液；请勿直接倒掉细胞培养液。 |
| 年龄（性别） | 男性；45岁 |
| 组织来源 | 腹水 |
| 细胞类型 | 肿瘤 |
| 肿瘤类型 | 淋巴瘤细胞 |
STR鉴定
-
STR位点信息
Amelogenin X,Y CSF1PO 10,11 D2S1338 18,24 D3S1358 18 D5S818 11 D7S820 11 D8S1179 13,14 D13S317 11,12 D16S539 11 D18S51 15 D19S433 11,13 D21S11 29,31.2 FGA 22 PentaD 9,12 PentaE 10 TH01 6,8 TPOX 8 vWA 15,16 D6S1043 12 D12S391 17 D2S441 14 -
STR鉴定图
-
参考文献
-
Targeting HDACs for diffuse large B-cell lymphoma therapy (2024-01-02)
作者：Chunyan Wu:1.Department of Hematology, The Affiliated Hospital of Qingdao University, No.16 Jiangsu Road, Qingdao, 266003, Shandong, China. ; Qiao Song:1.Department of Hematology, People's Hospital of Jiyang District, Jiyang, 251400, Shandong, China. ; Sophie Gao:1.Hunter College High School, New York, USA. ; Shaoling Wu:1.Department of Hematology, The Affiliated Hospital of Qingdao University, No.16 Jiangsu Road, Qingdao, 266003, Shandong, China. qdwushaoling@163.com. ;
期刊：Targeting HDACs for diffuse large B-cell lymphoma therapy
DOI：10.1038/s41598-023-50956-x
影响因子 ：4.6
引用产品： DB 细胞 , RPMI-1640 培养基 , 特级胎牛血清
-
Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by regulating the PI3K/AKT/mTOR pathway (2024-02-21)
作者：Chunyan Wu:1.Department of Hematology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266003, Shandong, China. ; Shilv Chen:1.Department of Hematology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266003, Shandong, China. ; Zhimin Wu:1.Department of Hematology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266003, Shandong, China. ; Jiao Xue:1.Department of Hematology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266003, Shandong, China. ; Wen Zhang:1.Department of Hematology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266003, Shandong, China. ; Shan Wang:1.Department of Hematology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Qingdao, 266003, Shandong, China. ; Xindong Zhao:1.Department of Medicine, Qingdao University, Qingdao, China. ; Shaoling Wu:1.Department of Hematology, The Affiliated Hospital
期刊：Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by regulating the PI3K/AKT/mTOR pathway
DOI：10.1007/s00432-024-05615-7
影响因子 ：3.6
引用产品： DB 细胞 , SU-DHL-4 细胞 , RPMI-1640 培养基
-
Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma (2023-12-12)
作者：ChaoFeng Zhang:1.Department of Haematology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China. ; 2.Department of Hematology and Rheumatology, The Affiliated Hospital of Putian University, Putian, China. ; 3.The School of Basic Medicine, Putian University, Putian, China. ; Qi Lin:1.Department of Pharmacy, The Affiliated Hospital of Putian University, Putian, China. ; ChunTuan Li:1.Department of Haematology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China. ; Yang Qiu:1.The School of Basic Medicine, Putian University, Putian, China. ; JingYu Chen:1.The School of Basic Medicine, Putian University, Putian, China. ; XiongPeng Zhu:1.Department of Haematology, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, China. ;
期刊：Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma
DOI：10.3389/fimmu.2023.1277695
影响因子 ：7.3
引用产品： DB 细胞
-
Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment (2023-09-14)
作者：Wei-Wei Zheng:1.Key Laboratory of Pediatric Hematology and Oncology Ministry of Health and Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ; Hang Zhou:1.Key Laboratory of Pediatric Hematology and Oncology Ministry of Health and Pediatric Translational Medicine Institute, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. ; 2.Department of Pathology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China. ; Ping Li:1.Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200092, China. ; Shi-Guang Ye:1.Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai, 200092, China. ; Tuersunayi Abudureheman:1.Key Laboratory of Pediatric Hematology and Oncology Ministry of Health and Pediatric Translational Medicine Institute, Shanghai Children
期刊：Anti-CD79b/CD3 bispecific antibody combined with CAR19-T cells for B-cell lymphoma treatment
DOI：10.1007/s00262-023-03526-z
影响因子 ：5.8
引用产品： SU-DHL-4 细胞 , DB 细胞
-
FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling (2023-11-21)
作者：Xiaojing Xing:1.Department of Hematology and Breast Cancer, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang, China. ; Meichen Liu:1.Department of Hematology and Breast Cancer, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang, China. ; Xuguang Wang:1.Department of Pathology, Shenyang Medical College, Shenyang, China. ; Qianxue Guo:1.Department of Hematology and Breast Cancer, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang, China. ; Hongyue Wang:1.Department of Scientific Research and Academic, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital & Institute), Shenyang, China. ; Wenxue Wang:1.State Key Laboratory of Robotics, Shenyang Institute of Automation, Chinese Academy of Sciences, Shenyang, China. ; 2.Institutes for Robotics and Intelligent Manufacturing, Chinese Academy of Sciences, Shenyang, China
期刊：FKBP3 aggravates the malignant phenotype of diffuse large B-cell lymphoma by PARK7-mediated activation of Wnt/β-catenin signalling
影响因子 ：5.3
-
Promoting effects of calponin 3 on the growth of diffuse large B‑cell lymphoma cells (2023-01-13)
作者：Xiaojing Xing:1.Department of Hematology and Breast Cancer, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital and Institute), Shenyang, Liaoning 110042, P.R. China. ; Meichen Liu:1.Department of Hematology and Breast Cancer, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital and Institute), Shenyang, Liaoning 110042, P.R. China. ; Xuguang Wang:1.Department of Pathology, Shenyang Medical College, Shenyang, Liaoning 110034, P.R. China. ; Qianxue Guo:1.Department of Hematology and Breast Cancer, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital and Institute), Shenyang, Liaoning 110042, P.R. China. ; Hongyue Wang:1.Department of Scientific Research and Academic, Cancer Hospital of Dalian University of Technology (Liaoning Cancer Hospital and Institute), Shenyang, Liaoning 110042, P.R. China. ;
期刊：Promoting effects of calponin 3 on the growth of diffuse large B‑cell lymphoma cells
影响因子 ：4.2
引用产品： DB 细胞
-
Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells (2023-03-26)
作者：Xiaojing Xing:1.Department of Hematology and Breast Cancer, Cancer Hospital of China Medical University (Liaoning Cancer Hospital & Institute), Shenyang, China. ; Xuguang Wang:1.Department of Pathology, Shenyang Medical College, Shenyang, China. ; Meichen Liu:1.Department of Hematology and Breast Cancer, Cancer Hospital of China Medical University (Liaoning Cancer Hospital & Institute), Shenyang, China. ; Qianxue Guo:1.Department of Hematology and Breast Cancer, Cancer Hospital of China Medical University (Liaoning Cancer Hospital & Institute), Shenyang, China. ; Hongyue Wang:1.Department of Scientific Research and Academic, Cancer Hospital of China Medical University (Liaoning Cancer Hospital & Institute), Shenyang, China. ;
期刊：Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells
DOI：10.1080/15384047.2023.2193114
影响因子 ：3.6
引用产品： DB 细胞
-
A miR-129-5P/ARID3A Negative Feedback Loop Modulates Diffuse Large B Cell Lymphoma Progression and Immune Evasion Through Regulating the PD-1/PD-L1 Checkpoint (2010-01-20)
作者：Weili Zheng:1.Fujian Provincial Key Laboratory on Hematology, Fujian Medical Center of Hematology, Fujian Institute of Hematology, Clinical Research Center for Hematological Malignancies of Fujian Province, Fujian Medical University Union Hospital, Fuzhou, China. ; Guilan Lai:1.Fujian Provincial Key Laboratory on Hematology, Fujian Medical Center of Hematology, Fujian Institute of Hematology, Clinical Research Center for Hematological Malignancies of Fujian Province, Fujian Medical University Union Hospital, Fuzhou, China. ; Qiaochu Lin:1.Fujian Provincial Key Laboratory on Hematology, Fujian Medical Center of Hematology, Fujian Institute of Hematology, Clinical Research Center for Hematological Malignancies of Fujian Province, Fujian Medical University Union Hospital, Fuzhou, China. ; Mohammed Awal Issah:1.Fujian Provincial Key Laboratory on Hematology, Fujian Medical Center of Hematology, Fujian Institute of Hematology, Clinical Research Center for Hematological Malignancies of Fu
期刊：A miR-129-5P/ARID3A Negative Feedback Loop Modulates Diffuse Large B Cell Lymphoma Progression and Immune Evasion Through Regulating the PD-1/PD-L1 Checkpoint
影响因子 ：5.5
引用产品： DB 细胞
-
Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma (2008-01-20)
作者：Weili Zheng:1.Fujian Institute of Hematology, Fujian Medical Center of Hematology, Fujian Provincial Key Laboratory on Hematology; Fujian Medical University Union Hospital, Fuzhou, China. ; Qiaochu Lin:1.Fujian Institute of Hematology, Fujian Medical Center of Hematology, Fujian Provincial Key Laboratory on Hematology; Fujian Medical University Union Hospital, Fuzhou, China. ; Mohammed Awal Issah:1.Fujian Institute of Hematology, Fujian Medical Center of Hematology, Fujian Provincial Key Laboratory on Hematology; Fujian Medical University Union Hospital, Fuzhou, China. ; Ziyuan Liao:1.Meng Chao Hepatobiliary Hospital Affiliated to Fujian Medical University, Fuzhou, China. ; Jianzhen Shen:1.Fujian Institute of Hematology, Fujian Medical Center of Hematology, Fujian Provincial Key Laboratory on Hematology; Fujian Medical University Union Hospital, Fuzhou, China. shenjianzhen@fjmu.edu.cn. ;
期刊：Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma
DOI：10.1186/s12885-021-08660-4
影响因子 ：3.8
引用产品： DB 细胞
-
MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1) (2011-01-20)
作者：Yan Wang:1.Department of Hematology, Taian City Central Hospital, Taian, Shandong, PR China. ; Dongmei Guo:1.Department of Hematology, Taian City Central Hospital, Taian, Shandong, PR China. ; Banban Li:1.Department of Hematology, Taian City Central Hospital, Taian, Shandong, PR China. ; Yanyan Wang:1.Department of Hematology, Taian City Central Hospital, Taian, Shandong, PR China. ; Bo Wang:1.Department of Hematology, Taian City Central Hospital, Taian, Shandong, PR China. ; Zan Wang:1.Department of Hematology, Taian City Central Hospital, Taian, Shandong, PR China. ; Meng Wang:1.Department of Hematology, Taian City Central Hospital, Taian, Shandong, PR China. ; Qingliang Teng:1.Department of Hematology, Taian City Central Hospital, Taian, Shandong, PR China. Electronic address: Lalalateng123@163.com. ;
期刊：MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1)
DOI：10.1016/j.leukres.2021.106769
影响因子 ：2.7
FAQs
Q：{{item.question}}
A：
产品资料
识别码示意图
